Authors: Ishiga, K Kawatani, T Suou, T Tajima, F Omura, H Idobe, Y Kawasaki, H

Citation: K. Ishiga et al., Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia, INT J HEMAT, 73(1), 2001, pp. 115-118

Authors: Kawatani, T Suou, T Tajima, F Ishiga, K Omura, H Endo, A Ohmura, H Ikuta, Y Idobe, Y Kawasaki, H

Citation: T. Kawatani et al., Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies, EUR J HAEMA, 67(1), 2001, pp. 45-50

Authors: Koda, M Murawaki, Y Mitsuda, A Oyama, K Okamoto, K Idobe, Y Suou, T Kawasaki, H

Citation: M. Koda et al., Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma - A randomized control study, CANCER, 92(6), 2001, pp. 1516-1524

Authors: Murawaki, Y Ikuta, Y Idobe, Y Kawasaki, H

Citation: Y. Murawaki et al., Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis, J GASTR HEP, 14(2), 1999, pp. 138-145

Authors: Koda, M Murawaki, Y Idobe, Y Horie, Y Suou, T Kawasaki, H Ikawa, S

Citation: M. Koda et al., Is choledocholithiasis a late complication of nonresectional therapies forhepatocellular carcinoma?, HEP-GASTRO, 46(30), 1999, pp. 3091-3094